David Freeman
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Pharmacogenetics and Drug Metabolism 5
-
- Renal Transplantation Outcomes and Treatments 2
- Co-authors
- Elzbieta M. Kurowska (1 shared paper)James D. Koropatnick (1 shared paper)Peter J. Ferguson (1 shared paper)Ann F. Chambers (1 shared paper)Michael John Rieder (5 shared papers)I.J. McGilveray (1 shared paper)J Jeffery (1 shared paper)THOMAS G. ROSANO (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (3 papers)Clinical Chemistry (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Blood Purification (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- CanadaUnited StatesSerbia
In The Last Decade
David Freeman
16 papers receiving 547 citations
Peers
Comparison fields: 5 of 75
- Transplantation 90
- Biochemistry 86
- Pharmacology 77
- Toxicology 27
- Nephrology 45
Countries citing papers authored by David Freeman
This map shows the geographic impact of David Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Freeman more than expected).
Fields of papers citing papers by David Freeman
This network shows the impact of papers produced by David Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Freeman. The network helps show where David Freeman may publish in the future.
Co-authors
The 25 scholars most cited alongside David Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 199 | |
| 2 | 1990 | 89 | |
| 3 | 1997 | 89 | |
| 4 | 1995 | 48 | |
| 5 | 1995 | 44 | |
| 6 | 1999 | 36 | |
| 7 | 2011 | 28 | |
| 8 | 2009 | 19 | |
| 9 | 1993 | 14 | |
| 10 | 1991 | 12 | |
| 11 | Changes in blood enzyme activity and hematology of rats with decompression sickness. | 1976 | 9 |
| 12 | 1991 | 9 | |
| 13 | 2009 | 5 | |
| 14 | 1996 | 3 | |
| 15 | 2017 | 2 | |
| 16 | 1999 | 1 |
About David Freeman
David Freeman is a scholar working on Pharmacology, Transplantation, Psychiatry and Mental health, Emergency Medicine and Nephrology, having authored 16 papers that have together received 607 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Schizophrenia research and treatment (3 papers), Poisoning and overdose treatments (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Phytochemicals and Antioxidant Activities (1 paper), Berry genetics and cultivation research (1 paper), Clinical Laboratory Practices and Quality Control (1 paper) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Transplantation (90 citations), Biochemistry (86 citations), Pharmacology (77 citations), Toxicology (27 citations) and Nephrology (45 citations). David Freeman has collaborated with scholars based in Canada, United States and Serbia. Frequent co-authors include Elzbieta M. Kurowska, James D. Koropatnick, Peter J. Ferguson, Ann F. Chambers, Michael John Rieder, I.J. McGilveray, J Jeffery, THOMAS G. ROSANO, Leslie M. Shaw and Paul A. Keown. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Clinical Chemistry, The Journal of Clinical Endocrinology & Metabolism, Blood Purification and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.